Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Kosmas%2C+Constantine+E%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Kosmas%2C+Constantine+E%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Kosmas%2C+Constantine+E%22&type=Person&sort=year
PubPharm (57)
1
Is inverse association between lipoprotein(a) and diabetes mellitus another paradox in cardiometabolic medicine?
enthalten in:
Expert review of endocrinology & metabolism
| 2024
von
Tsamoulis, D.
|
Kosmas, C.
|
Rallidis, L.
Wird geladen...
2
Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a)
enthalten in:
International journal of molecular sciences
| 2023
von
Kosmas, C.
|
Bousvarou, M.
|
Papakonstantinou, E.
| +5
Wird geladen...
3
Insulin resistance and cardiovascular disease
enthalten in:
The Journal of international medical research
| 2023
von
Kosmas, C.
|
Bousvarou, M.
|
Kostara, C.
| +3
Wird geladen...
4
The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
enthalten in:
Diagnostics (Basel, Switzerland)
| 2023
von
Kosmas, C.
|
Rodriguez Polanco, S.
|
Bousvarou, M.
| +4
Wird geladen...
5
Environmental Factors Modifying HDL Functionality
enthalten in:
Current medicinal chemistry
| 2022
von
Kosmas, C.
|
Sourlas, A.
|
Guzman, E.
| +1
Wird geladen...
6
Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
enthalten in:
Clinical pharmacology : advances and applications
| 2022
von
Kosmas, C.
|
Bousvarou, M.
|
Sourlas, A.
| +4
Wird geladen...
7
Environmental Factors Modifying HDL Functionality
enthalten in:
Current medicinal chemistry
| 2022
von
Kosmas, C.
|
Sourlas, A.
|
Guzman, E.
| +1
Wird geladen...
8
New and emerging lipid-modifying drugs to lower LDL cholesterol
enthalten in:
Drugs in context
| 2021
von
Kosmas, C.
|
Pantou, D.
|
Sourlas, A.
| +3
Wird geladen...
9
Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes
enthalten in:
Frontiers in physiology
| 2021
von
Xu, L.
|
Xu, C.
|
Liu, X.
| +13
Wird geladen...
10
Inclisiran for the Treatment of Cardiovascular Disease : A Short Review on the Emerging Data and Therapeutic Potential
enthalten in:
Therapeutics and clinical risk management
| 2020
von
Kosmas, C.
|
Muñoz Estrella, A.
|
Skavdis, A.
| +3
Wird geladen...
1
2
3
4
5
6
Nächster »
[6]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
57
Aufsätze
53
E-Artikel
53
E-Ressourcen
4
Gedruckte Aufsätze
Zeitschriftentitel
6
Drugs in context
5
Annals of translational medicine
4
Cardiology in review
4
Current heart failure reports
4
Heart failure reviews
4
The American journal of the medical sciences
3
Cardiovascular engineering and technology
3
Clinical Medicine Insights. Cardiology
2
Clinical pharmacology : advances and applications
2
Current medicinal chemistry
2
Therapeutic advances in cardiovascular disease
2
World journal of cardiology
1
American journal of therapeutics
1
Clinical medicine insights. Case reports
1
Clinical medicine insights. Endocrinology and d...
1
Congestive heart failure (Greenwich, Conn.)
1
Current opinion in lipidology
1
Diagnostics (Basel, Switzerland)
1
Diseases (Basel, Switzerland)
1
Expert review of endocrinology & metabolism
Alle anzeigen ...
weniger ...
Thema
43
Journal Article
41
Review
9
cardiovascular disease
7
Heart failure
5
cardiovascular risk
4
Renal denervation
4
Sympathetic nervous system
4
cardiovascular disease (CVD)
3
Aldosterone synthase inhibitor
3
Angiotensin converting enzyme inhibitor
3
Angiotensin receptor blocker
3
Angiotensin type 2 receptor agonist
3
Combination drug therapy
3
Direct renin inhibitor
3
Editorial
3
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
Lipoprotein(a)
3
Mineralocorticoid receptor blocker
3
Neurohormonal network
3
Reduced ejection fraction
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
56
2000-
1
1900-1999
Erscheinungsjahr(e)
Von:
Bis:
Sprache
56
Englisch
Haven't found what you're looking for?
Wird geladen...